Kobe C - Search Results

1

Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

Kobe C, Scheffler M, Holstein A, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Dietlein M, Wolf J, Kahraman D. Kobe C, et al. Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1117-27. doi: 10.1007/s00259-012-2118-8. Epub 2012 Apr 14. Eur J Nucl Med Mol Imaging. 2012. PMID: 22526960

2

[The incidentaloma of the thyroid. Over- or underuse of diagnostic procedure for an epidemiologic finding?].

Dietlein M, Kobe C, Schmidt M, Schicha H. Dietlein M, et al. Among authors: kobe c. Nuklearmedizin. 2005;44(5):213-24; quiz N41-2. Nuklearmedizin. 2005. PMID: 16395498 German.

3

[Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].

Dietlein M, Dederichs B, Kobe C, Theissen P, Schmidt M, Schicha H. Dietlein M, et al. Among authors: kobe c. Nuklearmedizin. 2006;45(1):21-34; quiz N1-2. doi: 10.1267/nukl06010021. Nuklearmedizin. 2006. PMID: 16493511 Review. German.

4

Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?

Marx K, Moka D, Schomäcker K, Fischer T, Gabruk-Szostak B, Kobe C, Dietlein M, Schicha H. Marx K, et al. Among authors: kobe c. Nucl Med Commun. 2006 Apr;27(4):353-8. doi: 10.1097/01.mnm.0000199475.08407.e2. Nucl Med Commun. 2006. PMID: 16531921

5

Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.

Schnell R, Dietlein M, Schomäcker K, Kobe C, Borchmann P, Schicha H, Hallek M, Engert A. Schnell R, et al. Among authors: kobe c. Onkologie. 2008 Feb;31(1-2):49-51. doi: 10.1159/000111758. Epub 2008 Jan 22. Onkologie. 2008. PMID: 18268399

6

Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?

Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Kobe C, et al. Nuklearmedizin. 2008;47(1):13-7. Nuklearmedizin. 2008. PMID: 18278207

7

Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.

Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H. Schmidt M, et al. Among authors: kobe c. Thyroid. 2008 Jul;18(7):755-60. doi: 10.1089/thy.2008.0008. Thyroid. 2008. PMID: 18631004

8

Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?

Kobe C, Weber I, Eschner W, Sudbrock F, Schmidt M, Dietlein M, Schicha H. Kobe C, et al. Nuklearmedizin. 2008;47(4):153-6. Nuklearmedizin. 2008. PMID: 18690374

9

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.

Kobe C, Dietlein M, Franklin J, Markova J, Lohri A, Amthauer H, Klutmann S, Knapp WH, Zijlstra JM, Bockisch A, Weckesser M, Lorenz R, Schreckenberger M, Bares R, Eich HT, Mueller RP, Fuchs M, Borchmann P, Schicha H, Diehl V, Engert A. Kobe C, et al. Blood. 2008 Nov 15;112(10):3989-94. doi: 10.1182/blood-2008-06-155820. Epub 2008 Aug 29. Blood. 2008. PMID: 18757777 Free PMC article. Clinical Trial.

10

Perrault Syndrome with progressive nervous system involvement.

Kobe C, Kracht LW, Timmermann L, Bachmann J, Schmidt MC. Kobe C, et al. Clin Nucl Med. 2008 Dec;33(12):922-4. doi: 10.1097/rlu.0b013e31818c4e25. Clin Nucl Med. 2008. PMID: 19033811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters